CompanyHRTXNasdaqSan Diego, CA

Heron Therapeutics, Inc. /De/

Commercial-stage biotechnology company developing therapeutics for acute care and oncology.

SEC EDGAR ClinicalTrials.gov herontx.com

8-KSep 29Latest SEC filing

Sep 29Latest story

September 2026

Heron Therapeutics signs multi-product license deal with Long Grove Pharmaceuticals

Sep 29PartnershipHeron Therapeutics, Inc. /De/

August 2026

Heron Therapeutics extends tax benefit preservation plan to 2029

Aug 14PartnershipHeron Therapeutics, Inc. /De/

Heron withdraws 2026 guidance, weighs strategic alternatives after CINVANTI ruling

Aug 10Quarterly updateaprepitant Heron Therapeutics, Inc. /De/